StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3022% above fair value
$1347.11−4.01 (-0.30%)

Close on Nov 20, 2026Market cap $1.27TP/E 43.7Yield 0.46%

Eli Lilly Capitalized pre-launch inventory by Year

Capitalized pre-launch inventory ($M) ($M)

Eli Lilly Capitalized pre-launch inventory: $1,500M in FY2025, up 173.7% from a year earlier.

Latest, FY2025
1,500
Period ended Dec 31, 2025
Change on a year earlier
+173.7%
548 in FY2024
History
2 years
Since FY2024
Sources
2
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-12) ↗

Reported in Form 10-K Inventories Note.

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCapitalized pre-launch inventory ($M) ($M)Year on yearSource
FY2025Dec 31, 20251,500+173.7%Form 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 2024548–Form 10-Q (filed 2025-08-07) ↗

Cite this data

StockData. (2026). Eli Lilly Capitalized pre-launch inventory ($M), annual FY2024–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/inv-prelaunch-cap

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.

See a number that looks wrong?